People

Building a human-cell neuroscience lab in Oslo

We use human stem-cell-derived neural tissue to find out how drugs, pollutants and disease change the brain, and we design the work so the evidence can inform real decisions. The lab is new, so the people who join first help shape it.

Illustration: four roles overlapping around one project. Four overlapping circles labelled postdoc, PhD, master's and technician meet in a central circle labelled project.
Portrait of Denis Zosen

Principal investigator

Denis Zosen, PhD, MBA

I work on what happens to the developing human brain when a drug or a pollutant arrives, and on why the answer has been so hard to pin to a moment in time. That question has followed me through four countries and two very different model systems. It started with p53 and the MAPK cascade in St Petersburg, where I found that the same signalling that pushes a cell to differentiate also restrains what it secretes: the direction of a drug effect depends on the state the cell is in.

During my doctorate in Oslo I built a chicken embryo model to ask where drugs actually reach in the developing brain, and showed that they arrive within minutes at clinically relevant concentrations, with penetration depending on developmental stage. Twice since then I have watched a single endpoint point the wrong way: antiepileptics with different morphological signatures converging on one transcription factor, and antidepressants raising the reassuring molecular marker while cutting neurite outgrowth. That is why the current work reads several orthogonal endpoints in the same cells rather than trusting any one of them.

Alongside the bench work I have spent time where preclinical evidence is actually used, in drug development and clinical research. I have watched how that evidence is weighed when a real decision about human exposure has to be made, and where it fails to answer the question being asked of it. The programme I am building is aimed at that failure. The steps in between are on the research path page.

What I like most about this job is the moment a stuck experiment, an unwritten paper or an unfunded idea comes unstuck. If you work with me, that is what I am here for.

Career

  • 2026 to nowGuest Researcher, NCMBM, University of OsloNorwegian node of the Nordic EMBL Partnership for Molecular Medicine
  • 2024 to nowCoordinator for Clinical Trials, ICON Clinical Research (embedded at MSD), OsloOperational and financial portfolio coordination for 25 sites across 10+ clinical programmes; Local Safety Officer
  • 2024 to nowExpert Reviewer, biotech and healthcare ventures, BioExpert Network and Capital Cell, remote, EUScientific viability, innovation, risk and market potential of early-stage ventures, as part of the scientific due diligence; 30+ reviews completed within a network of 300+ reviewers
  • 2023 to 2024Project Lead, P1M, OsloEvidence platform for oncology clinicians and patients; led a team of clinicians, engineers and data scientists
  • 2018 to 2022Doctoral Researcher, Neurobiology and Toxicology Lab, University of OsloFour preclinical programmes; five of my twelve papers; three research grants; taught four core courses
  • 2021Innovation Fellow, Merck KGaA Innovation Center, DarmstadtLed five scientists from idea to proof of concept; secured €250,000 in seed funding
  • 2017 to 2018Visiting Researcher, Developmental Biology Lab, Biocenter Oulu, University of OuluWnt signalling in CNS development; CRISPR editing, iPSC-derived organoids and imaging, on funding I secured myself
  • 2018Short-Term Scientific Mission Researcher, Norwegian Centre for Stem Cell Research, Oslo University HospitaliPSC differentiation, cerebral organoid production; EU COST Action BIONECA
  • 2012 to 2017Junior Researcher, Comparative Biochemistry of Cellular Functions Lab, Sechenov Institute of Evolutionary Physiology and Biochemistry RAS, St PetersburgCell signalling and molecular mechanisms of development and pathology

Education

  • 2023Master in Business Administration (MBA), Quantic School of Business and TechnologyFocus on management and leadership. Zenith Award for Academic Excellence; top 20% of class
  • 2022PhD in Pharmaceutical Biosciences, University of OsloAction of Neuroactive Pharmaceuticals in Neurodevelopmental Models. Supervisor Prof. Ragnhild E. Paulsen; co-supervisors Prof. Joel C. Glover and Dr Sigrid Bjørnstad. Defended 14 December 2022
  • 2021University Pedagogical Basic Competence, LINK, University of Oslo200+ hours of certified pedagogical training
  • 2016MSc in Cell Biology, Cytology, Histology & Immunology, Saint Petersburg State UniversityMagna cum laude; Best Master's Thesis award
  • 2014BSc in Physiology and Biomedicine, Saint Petersburg State UniversityL. A. Orbeli scholarship for student research, 2013 to 2015

Funding won as applicant

  • 2021Seed funding of €250,000 from Merck KGaA Innovation Center, DarmstadtAdvanced Cell Models innovation project
  • 2020 to 2021Research grant of NOK 34,000 from the S. G. Sønneland Foundation, Oslo“3D or not 3D? Approaching human neurodevelopment in a dish”
  • 2019, 2021Two research analysis grants of NOK 30,000 each, University of Oslo
  • 2018Short-term scientific mission grant of €4,500 from EU COST Action BIONECA CA16122iPSC differentiation and cerebral organoids
  • 2017 to 2018Research visit grant of about €27,000 from the Finnish National Agency for EducationFunctions of Wnt secreted signals in central nervous system development

Recognition

  • 2023, 2025Selected as one of 100 global leaders, Global Biotech Revolution forum, University of Cambridge
  • 2025Invited panel speaker, DLN Research School Conference
  • 2021 to 2022Social Media Ambassador, Federation of European Neuroscience SocietiesCross-disciplinary neuroscience for a community of 5,000+ members

Peer review

I review manuscripts on developmental neurobiology and neurotoxicology, human iPSC-derived neural models and organoids, neuronal and glial differentiation, drug distribution and drug effects in the developing brain, mechanistic studies of neurodevelopmental and neurodegenerative disorders, and in vitro methods that replace animal experiments. Editors are welcome to invite me, and authors to suggest me, as a reviewer. I decline manuscripts where I have a conflict of interest, and I keep every manuscript confidential. Reviews go through the journal's own system. You can reach me at denis.zosen@ncmbm.uio.no. I am registered as a reviewer with BMJ Open and MDPI.

The team

The first team has three roles: a postdoctoral researcher, a PhD candidate and a research technician. None is advertised yet. Each card lists the skills I look for, so you can see how to prepare.

  • Baton, a ginger cat in round glasses and a teal bowtie, standing in as the postdoctoral researcher

    Postdoctoral researcher

    Empty seat

    Skills and competences I look for

    • A PhD in neuroscience, developmental or stem cell biology, or a close field
    • Hands-on iPSC culture and 3D neural models, with a record of making them reproducible
    • Single-cell or bulk sequencing analysis in R or Python, written so that others can rerun it
    • Imaging and image analysis, or electrophysiology
    • Experiments designed with pre-set decision criteria, and statistics that go past the p-value
    • Writing papers and grants, and mentoring a student
  • Baton, a ginger cat in a graduation cap, standing in as the PhD candidate

    PhD candidate

    Empty seat

    Skills and competences I look for

    • An MSc in biomedical science, biochemistry, pharmacology, neuroscience or similar
    • Patient, careful cell culture and sterile technique
    • A habit of doubting your own result, and a tidy lab notebook
    • Basic statistics and some programming in R or Python, or the wish to learn
    • Critical reading of papers, and clear writing in English
    • Willingness to work in a pair, sharing the early experiments and the early workload
  • Baton, a ginger cat in safety goggles, standing in as the research technician

    Research technician

    Empty seat

    Skills and competences I look for

    • Cell culture and aseptic technique, with iPSC experience as a plus
    • Molecular biology: qPCR, western blot and immunostaining
    • Running a lab: stock, orders, equipment upkeep, safety and waste routines
    • Exact record-keeping in an electronic lab notebook
    • Following a protocol faithfully, and improving it when it falls short
    • Reliability, initiative and a calm head on a busy day

Until real people sit in these seats, Baton, the lab mascot, is standing in. Applications from cats will be considered only with a PhD.

Positions at the University of Oslo are state posts. Under the State Employees Act and university rules they are, as a rule, advertised publicly and filled in open competition on qualifications. I can give my view, but it is the appointment committee that has to be convinced, so I cannot promise a post to anyone. Coming with your own funding, such as a fellowship, is a different route and always welcome.

How the roles share the work

Every role has a floor and a bold part. The floor is what must be delivered. The bold part is work I plan so that it can fail. Most of each role is careful routine work, which is also where surprises are first noticed. The floor protects time for careful work. The bold part protects room to try something that may fail.

The bold part tests a hypothesis that, if true, would change the plan, and has its stop rule (the result that ends the idea) written before the first experiment. The floor is everything else. Both terms describe how I plan, and say nothing about how important a result will be. The Research page shows how I separate what can be planned from what is important.

Floor and bold part for each role
RoleFloor: what must be deliveredBold part: allowed to fail
Master’s studentA thesis that meets the programme’s requirements, on time, on a defined question with a low-risk design.One small hypothesis test or pilot, chosen together. The project is designed so that the thesis does not depend on it working.
PhD candidateThe thesis, with a written fallback for each aim.At least one aim built to be able to fail, with thresholds fixed in advance, within the project description agreed at admission.
Postdoctoral researcherDrives the project and keeps it on time. Shares the day-to-day guidance of master’s and PhD work with me, within the formal supervision arrangement.Their own question, with the aim that they lead the resulting paper. Authorship, including who corresponds, is agreed in writing before the work starts and follows journal and University rules.
Research technicianReliable records, stock, equipment and protocols, with each protocol taken from version 0.1 to 1.0.None required. Proposals to improve a protocol are welcome.

What keeps this fair

  • A bold part that fails is written up in the notebook with its result. A result that does not fit the plan is followed up, not set aside.
  • Examiners grade a master’s thesis on the programme’s criteria.
  • Formal supervision follows University of Oslo rules. At the start I say who the main supervisor is for each person.
  • If bold work and the floor compete for time, the floor comes first.

Interested before a seat opens? See Join us, or write to me.